The Therapeutic Cannabis Program has remained largely unchanged since medical cannabis was legalized in 2014. Leafly's state-by-state testing guide, last updated January 23, 2024, puts it plainly: New Hampshire "is one of the few states that omits" metals from its contaminant panel, and its testing regulations "have remained largely unchanged since 2014." Oversight sits with the Department of Health and Human Services, which regulates the state's Alternative Treatment Centers. A 2023 update let patient certifications run for up to three years. What you will not find anywhere in the current program is a published CFU-per-gram ceiling for yeast and mold on flower. The number operators keep searching for is not in the statute.
Where the CBD-hemp statute (HB 272) applies, and where it does not
Here is the piece that muddies every search result. New Hampshire's most detailed testing language lives in HB 272, which covers CBD products derived from hemp. Section 146:23 requires a third-party certificate of analysis listing, among other contaminants, "mold, bacteria, and yeast." Read in isolation, that looks like a mold-testing mandate for cannabis. It is not. The same bill states: "The therapeutic cannabis program established under RSA 126-X shall be exempt from the provisions of this subdivision." The detailed testing statute explicitly carves out medical cannabis. If your operation touches both hemp CBD and medical flower, the two product lines sit under different rules, and conflating them is the most common compliance mistake we see in a market this early.
How New Hampshire compares to its neighbors
New Hampshire's silence reads differently once you line it up against the region. Massachusetts enforces a published limit of 10,000 CFU/g total yeast and mold on flower. New York sets total yeast-and-mold thresholds. Maine and Vermont each took their own path on microbial testing. The regional pattern is consistent: as each New England market matured, it tightened microbial limits rather than loosening them. For an operator tracking state variance (ICP#3) or evaluating New Hampshire market entry (ICP#4), the useful move is to adopt an adjacent-state number as an internal target now, so the program is already running to a real ceiling before the state writes one. Our Massachusetts, Maine, Vermont, and New York compliance briefs carry those neighbor thresholds in detail.
What adult-use legalization will likely require
New Hampshire adult-use legalization is pending, not passed. HB 1633 (2024) and earlier HB 639 iterations proposed frameworks; none had become law as of capture. The forecast is not a guess so much as a pattern read: when New Hampshire follows the Massachusetts, Maine, and Vermont precedent, published microbial thresholds and mandatory batch testing are the likely baseline. Operators who stood up air-quality and sanitation documentation in 2024 will hold a licensing advantage when readiness reviews begin. The honest framing is that you cannot control what the state publishes next, but you can control what your certificates of analysis and your facility logs look like today.
Building a mold prevention program that survives the next rule change
A program that outlasts a threshold change rests on four records: an air-quality baseline you document continuously, a between-cycle room turnover protocol, surface sanitation with EPA-registered disinfectants, and applicator certification where New Hampshire requires it. On that last point, N.H. Admin. Code Pes 302.01 defines an F8 "microbial pest control" applicator category covering commercial applicators using pesticides to control mold, fungi, and bacteria. Any cultivator using a pesticide-registered microbial control agent should confirm whether F8 certification applies to their program, and confirm current requirements with the state regulator, because New Hampshire does not publish cannabis-specific CFU thresholds that would settle it for you.
The EPA compliance layer
Product registration and product claim are two different things, and in a regulated market you keep them separate. ProKure V is the EPA-registered liquid Hospital-Type Disinfectant (EPA Reg. No. 87508-3-89334) for hard, non-porous surfaces such as benches, tools, grow beds, and drying rooms, and it is suitable for use with plants in the room. ProKure G is the fast-release gas used for an empty-room reset between cycles, and its label carries the restriction "not for use with/on plants/crops/feed," so it is an empty-structure tool only. ProKure D is a humidity-activated slow-release gas that improves air quality and controls odor and provides ClO2 protection for up to 30 days per pouch; it runs with plants in the room. D is not an EPA-registered product and not labeled for sale as a pesticide under 40 CFR. Keep each product on its own claim and its own label. Deep-detail labels, SDS, and EPA registration references live on prokuresolutions.com; product orders route to shop.groclarity.com.
Audit-ready documentation for New Hampshire ATCs
Even with no state-mandated CFU ceiling, an Alternative Treatment Center facing a DHHS re-licensure review is better off with a paper trail than without one. Keep four things current: air-test log inputs (install date, room, product, replace-by date, operator), a chemical inventory with EPA registration numbers, applicator certifications on file, and a written between-cycle sanitation SOP. That package is the argument that your facility managed microbial risk on purpose, not by luck, which is exactly the posture a regulator rewards in a market still writing its rules.
Work with GroClarity
GroClarity is based in Phoenix, Arizona, at 5013 E. Washington St. Ste. 130, Phoenix, AZ 85034, and works with cannabis cultivation facilities nationwide, by appointment. We build the air-quality baseline, the between-cycle protocol, and the audit documentation that New Hampshire operators will want in hand before adult-use thresholds arrive. Always read product labels before use.


